NASDAQ:HSDT Helius Medical Technologies (HSDT) Stock Price, News & Analysis → get a piece of the profit from this land (From True Market Insiders) (Ad) Free HSDT Stock Alerts $1.48 -0.04 (-2.63%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.45▼$1.5750-Day Range$1.48▼$6.4852-Week Range$1.45▼$14.44Volume231,929 shsAverage Volume906,501 shsMarket Capitalization$3.74 millionP/E RatioN/ADividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Helius Medical Technologies alerts: Email Address Helius Medical Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,521.6% Upside$24.00 Price TargetShort InterestHealthy7.57% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.12Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($6.26) to ($2.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.33 out of 5 stars 3.5 Analyst's Opinion Consensus RatingHelius Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageHelius Medical Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Helius Medical Technologies' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted7.57% of the float of Helius Medical Technologies has been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently decreased by 11.10%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HSDT. Previous Next 2.8 News and Social Media Coverage News SentimentHelius Medical Technologies has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.Search Interest5 people have searched for HSDT on MarketBeat in the last 30 days. MarketBeat Follows6 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.30% of the stock of Helius Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 18.63% of the stock of Helius Medical Technologies is held by institutions.Read more about Helius Medical Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Helius Medical Technologies are expected to grow in the coming year, from ($6.26) to ($2.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Helius Medical Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. About Helius Medical Technologies Stock (NASDAQ:HSDT)Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Read More HSDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSDT Stock News HeadlinesMay 15, 2024 | msn.comHelius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke ProgramMay 14, 2024 | msn.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 Helius Medical Technologies Inc Earnings CallMay 14, 2024 | finance.yahoo.comHelius Medical Technologies Inc (HSDT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | globenewswire.comHelius Medical Technologies, Inc. Reports First Quarter 2024 Financial ResultsMay 12, 2024 | americanbankingnews.comHelius Medical Technologies (HSDT) Scheduled to Post Quarterly Earnings on MondayMay 10, 2024 | financialpost.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 10, 2024 | globenewswire.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 9, 2024 | msn.comHelius Medical Technologies Awaits CMS Decision on Medicare Reimbursement Rates for Innovative DeviceMay 9, 2024 | americanbankingnews.comHelius Medical Technologies (NASDAQ:HSDT) Shares Down 0.6% May 7, 2024 | msn.comHelius Medical Technologies raises $6.4M via equity offeringMay 6, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public OfferingMay 6, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)May 3, 2024 | msn.comWhy Is Helius Medical Technology (HSDT) Stock Up 47% Today?May 3, 2024 | investorplace.comWhy Is Helius Medical Technology (HSDT) Stock Up 47% Today?April 24, 2024 | globenewswire.comHelius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterApril 21, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. (HSDT)April 17, 2024 | wsj.comHelius Medical Technologies Inc.April 15, 2024 | msn.comHelius Medical files to sell Class A common stock, warrantsApril 6, 2024 | msn.comHelius Medical Technologies Partners with Lovell to Bring Innovative MS Treatment to VeteransApril 3, 2024 | msn.comWhy Is Nano-Cap Helius Medical Stock Trading Higher On Wednesday?April 3, 2024 | seekingalpha.comHelius Medical Technologies signs partnership with Lovell Government ServicesApril 3, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™April 1, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comHelius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call TranscriptSee More Headlines Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/18/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HSDT CUSIPN/A CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees26Year Founded2014Price Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+1,521.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($13.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,850,000.00 Net Margins-1,328.14% Pretax Margin-1,328.14% Return on Equity-297.49% Return on Assets-107.36% Debt Debt-to-Equity RatioN/A Current Ratio3.51 Quick Ratio3.72 Sales & Book Value Annual Sales$640,000.00 Price / Sales5.85 Cash FlowN/A Price / Cash FlowN/A Book Value$0.79 per share Price / Book1.87Miscellaneous Outstanding Shares2,530,000Free Float2,345,000Market Cap$3.74 million OptionableNot Optionable Beta1.60 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 58)President, CEO & Director Comp: $469.17kDr. Antonella Favit-Van Pelt M.D. (Age 57)Ph.D., Chief Medical Officer Comp: $432.67kMr. Lawrence PiccianoSenior Vice President of Engineering, Quality & Regulatory AffairsKey CompetitorsNuwellisNASDAQ:CHFSNuwellisNASDAQ:NUWETivic Health SystemsNASDAQ:TIVCENDRA Life SciencesNASDAQ:NDRANeuBase TherapeuticsNASDAQ:NBSEView All CompetitorsInsidersDane AndreeffBought 5,000 shares on 12/14/2023Total: $40,500.00 ($8.10/share)Dane AndreeffBought 2,000 shares on 11/30/2023Total: $12,740.00 ($6.37/share)Dane AndreeffBought 5,000 shares on 8/30/2023Total: $38,200.00 ($7.64/share)Dane AndreeffBought 5,078 shares on 8/28/2023Total: $32,346.86 ($6.37/share)View All Insider Transactions HSDT Stock Analysis - Frequently Asked Questions Should I buy or sell Helius Medical Technologies stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSDT shares. View HSDT analyst ratings or view top-rated stocks. What is Helius Medical Technologies' stock price target for 2024? 1 equities research analysts have issued 1-year price objectives for Helius Medical Technologies' stock. Their HSDT share price targets range from $24.00 to $24.00. On average, they expect the company's stock price to reach $24.00 in the next year. This suggests a possible upside of 1,521.6% from the stock's current price. View analysts price targets for HSDT or view top-rated stocks among Wall Street analysts. How have HSDT shares performed in 2024? Helius Medical Technologies' stock was trading at $8.04 at the beginning of the year. Since then, HSDT shares have decreased by 81.6% and is now trading at $1.48. View the best growth stocks for 2024 here. When is Helius Medical Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our HSDT earnings forecast. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies, Inc. (NASDAQ:HSDT) released its earnings results on Thursday, March, 28th. The company reported ($1.47) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.05) by $2.58. The business had revenue of $0.13 million for the quarter, compared to analyst estimates of $0.18 million. Helius Medical Technologies had a negative trailing twelve-month return on equity of 297.49% and a negative net margin of 1,328.14%. When did Helius Medical Technologies' stock split? Shares of Helius Medical Technologies reverse split on Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Helius Medical Technologies? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSDT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.